Print

Lundbeck Inc. (formerly Ovation Pharmaceuticals) CFO: Elan Pharmaceuticals (ELN) Not an Acquisition Option Now  
5/13/2009 11:26:23 AM

Bookmark and Share

COPENHAGEN, May 13 (Reuters) - Danish pharmaceutical group Lundbeck (LUN.CO) would not be able to buy Irish biotech company Elan (ELN.I) in current market conditions, Lundbeck's Chief Financial Officer Anders Gotzsche said on Wednesday.

//-->